A VÁNDORGYŰLÉS HELYSZÍNE: Balatonfüred Kongresszusi Központ (8230 Balatonfüred, Huray u. 3.)

IDŐPONT: 2024.  szeptember 19-21.

További részletes információk és online jelentkezés  a Vándorgyűlés weboldalán

Dear Colleagues,

We invite you to the 14th Central European Congress of Rheumatology.

After eighteen years, this traditional biannual congress is going to be, for the second time, hosted by the Slovenian Medical Association – Section of Rheumatology.  In keeping with the tradition of the CECR, the rheumatologists from the member countries and distinguished international speakers are going to present and discuss their research and clinical experience in the diagnosis and treatment of rheumatologic conditions. The clinically based sessions are going to focus on burning topics chosen by the member scientific societies.

For the first time in the CECR’s history, there will be a dedicated pediatric rheumatology session, a session dedicated to transition of patients from pediatric to adult rheumatologists, and an opportunity for patient organizations to take part. This time, the meeting will be held at Cankarjev dom in the centre of the lovely Christmassy Slovenian capital Ljubljana. Cankarjev dom is a cultural and congress centre named after one of the greatest Slovenian novelists and overlooks the national Parliament.

Alongside the thought-provoking scientific program, we will certainly find time for exchanging views and ideas, successful local practices as well as socializing, strengthening friendships and strategizing further optimization of the delivery of care to our patients in the Central Europe.

Extension of the abstract submission deadline until including 26 August 2024.

Important dates:

• Abstract submission & Registration - OPEN
• Abstract submission closes – 26 August 2024
• Acceptance notification – 15 September 2024
• Early and Active Participants registration deadline – 1 October 2024

Submission Portal

Website

Kedves Kollégák!

Kérjük, amennyiben lehetőségük van rá, az alábbi felmérés kitöltésével segítsék munkánkat. A kérdőív angol nyelvű, a válaszadás mindössze pár percet vesz igénybe. A reprezentatív eredmény eléréséhez, minél nagyobb részvételi arány szükséges. Együttműködésüket köszönjük!

Dear colleague,

Methotrexate (MTX) is still our anchor drug used in Patients with Rheumatoid Arthritis. Nevertheless, the prescription patterns of MTX vary across centres and countries. As part of Horizon Europe project SQUEEZE, we aim to assess local practice of methotrexate (MTX) initiation and titration scheme in patients with rheumatoid arthritis (RA) across Europe. 

We are inviting all physicians treating patients with rheumatoid arthritis across different European countries and hospital/practice settings to take part in this survey. 

It will take approximately 10-15 minutes to complete the survey. You can save and return to your answers at any time (if you are not able to finish it at one time point or if you want to correct some of your responses). Please note the link needs to be completed from the same computer, if you want to fill out more than one survey this needs to be done on different computers. Please make sure you do not leave the survey half completed. We would like to emphasize that there are no right or wrong answers.

 You can contribute to research by simply using the link: https://de.surveymonkey.com/r/F7Q6LY3